Patrick Hwu, MD, is the president and CEO of Moffitt Cancer Center, one of the leading cancer hospitals in the US and the only National Cancer Institute-designated comprehensive cancer center based in Florida.
As an internationally recognized tumor immunologist, Hwu has led pioneering research and clinical efforts to better understand the interactions between tumors and the immune system. He helped launch the field of gene modified T cells, publishing research on the first chimeric antigen receptor directed against cancer. His work focuses on vaccines, adoptive T-cell therapies and immune resistance.
Prior to joining Moffitt, Dr. Hwu was the head of the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, where he held various leadership roles for 17 years.